Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unsealed Price-Fixing Complaint Reveals Emails

Executive Summary

Emails between major generics firms including Teva, Sandoz and Mylan have been revealed after a court unsealed a complaint filed by 44 US states claiming widespread price-fixing among numerous industry players.

You may also be interested in...



Teva Stays Silent On Settlement Suspension Stories

Amid media reports of Teva walking away from settlement negotiations with the US Department of Justice over generic price-fixing allegations, the Israeli company is officially maintaining silence over the matter.

Top US Court Lifts Discovery Stay On Price-Fixing

The US Supreme Court has lifted a stay on document discovery in a multi-state lawsuit in which dozens of generics companies – including Teva, Mylan and Pfizer – are accused of price fixing. The ruling will allow a swathe of documents to be released in what Connecticut’s attorney general has said is potentially “the largest cartel case” in US history.

Bernie Sanders Urges DoJ To Take Action On Price-Fixing Claims

Bernie Sanders and Elijah Cummings have written to the DoJ urging strict action against all generic drug manufacturing companies accused of a price-fixing conspiracy.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

GB140446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel